Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2010 • 14,016 citations

Cancer-related inflammation

2008 • 10,288 citations

Myeloid-derived suppressor cells as regulators of the immune system

2009 • 6,165 citations

Microenvironmental regulation of metastasis

2008 • 3,476 citations

Regulatory T Cells: Mechanisms of Differentiation and Function

2007 • 2,574 citations

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

2007 • 2,155 citations

The role of myeloid cells in the promotion of tumour angiogenesis

2008 • 1,574 citations

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

2004 • 1,111 citations

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

2010 • 1,030 citations

TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT

2006 • 972 citations

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

2008 • 865 citations

Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species

2004 • 825 citations

Oral Squamous Cell Carcinoma

2005 • 750 citations

TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck

2007 • 732 citations

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

2006 • 726 citations

Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells

2007 • 718 citations

Clinical significance of defective dendritic cell differentiation in cancer.

2000 • 694 citations

Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

2008 • 640 citations

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

2007 • 614 citations

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

2006 • 561 citations

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

2004 • 544 citations

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

2009 • 522 citations

Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells

2000 • 516 citations

Transforming growth factor-β in cancer and metastasis

2006 • 500 citations

Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma

2007 • 466 citations

Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease

2005 • 462 citations

Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.

2002 • 375 citations

Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod

2008 • 372 citations

Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density

2005 • 363 citations

Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung

2010 • 357 citations

Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.

2000 • 339 citations

Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

2003 • 332 citations

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

2007 • 309 citations

Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway

2005 • 308 citations

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

2011 • 295 citations

Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade

2010 • 293 citations

The Frequency and Suppressor Function of CD4+CD25highFoxp3+ T Cells in the Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck

2007 • 273 citations

Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome

2005 • 247 citations

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

2003 • 243 citations

Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege

2005 • 236 citations

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial

1999 • 231 citations

Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism

2011 • 231 citations

Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization

2004 • 221 citations

Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.

2002 • 214 citations

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

2008 • 188 citations

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study

2010 • 171 citations

Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01

2009 • 170 citations

Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis

1999 • 160 citations

T Regulatory Type 1 Cells in Squamous Cell Carcinoma of the Head and Neck: Mechanisms of Suppression and Expansion in Advanced Disease

2008 • 156 citations

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1996 • 155 citations

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation

2011 • 155 citations

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin-2 injected periiymphatically

1988 • 151 citations

Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant Recipients

1995 • 150 citations

Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

2010 • 133 citations

Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion

2006 • 132 citations

Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: Correlations with extent of tumor and prognosis

1986 • 126 citations

Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses

2004 • 115 citations

A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia

2007 • 113 citations

Human Leukocyte Antigen (HLA) Class I Defects in Head and Neck Cancer: Molecular Mechanisms and Clinical Significance

2005 • 108 citations

Phase I Study of Gefitinib Plus Celecoxib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

2005 • 104 citations

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

2005 • 100 citations

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.

2008 • 100 citations

Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial

2011 • 98 citations

11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours

2006 • 94 citations

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells.

1999 • 94 citations

Generation of T Cells Specific for the Wild-Type Sequence p53264–272 Peptide in Cancer Patients: Implications for Immunoselection of Epitope Loss Variants

2000 • 92 citations

Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.

2001 • 88 citations

Phase 1 study of concurrent sunitinib and image‐guided radiotherapy followed by maintenance sunitinib for patients with oligometastases

2009 • 88 citations

HPV-induced oropharyngeal cancer, immune response and response to therapy

2009 • 80 citations

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

2009 • 80 citations

Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma

2011 • 76 citations

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck

2009 • 66 citations

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

2009 • 61 citations

p53-Based Immunotherapy of Cancer

1998 • 61 citations

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

2011 • 59 citations

Possible prognostic value of histopathologic parameters in patients with carcinoma of the oral tongue

1998 • 58 citations

Human Papillomavirus Vaccines for Cervical Cancer

1999 • 49 citations

Role of cytokines in head and neck squamous cell carcinoma

2006 • 48 citations

Prognostic Significance of Tumor-Infiltrating Lymphocytes in Oropharyngeal Cancer

2007 • 48 citations

Antiproliferative Effects of Cytokines on Squamous Cell Carcinoma

1991 • 46 citations

Clinical and Immunopathological Results of a Phase II Study of Perilymphatically Injected Recombinant Interleukin-2 in Locally Far Advanced, Nonpretreated Head and Neck Squamous Cell Carcinoma

1991 • 45 citations

Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer Survival

2011 • 44 citations

Head and Neck Squamous Cell Carcinoma: New Translational Therapies

2010 • 43 citations

T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer

2010 • 38 citations

Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma

2010 • 36 citations

Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

2011 • 36 citations

Molecular and Clinicopathologic Comparisons of Head and Neck Squamous Carcinoma Variants

2004 • 35 citations

Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma

2006 • 33 citations

An MVA vaccine overcomes tolerance to human p53 in mice and humans

2007 • 27 citations

Ifosfamide in the Treatment of Head and Neck Cancer

2003 • 21 citations

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

1998 • 21 citations

The Efficacy of Imiquimod on Dysplastic Lesions of the Oral Mucosa: An Experimental Model

2010 • 19 citations

Expression of the T Cell Receptor αβ on a CD123+ BDCA2+ HLA-DR+ Subpopulation in Head and Neck Squamous Cell Carcinoma

2011 • 4 citations

Observations on preprofessional education: is there a "major" difference?

1991 • 1 citations